Fintech PR
Crypto Finance Partners with Figment to Enhance Its Staking Services for Institutional Clients
ZURICH, July 25, 2023 /PRNewswire/ — Crypto Finance, a pioneer in digital assets since 2017, trusted FINMA-regulated partner of financial institutions, and part of Deutsche Börse Group, announces its strategic partnership with Figment, a leading provider of staking infrastructure, to expand its protocol staking offering. The partnership combines Crypto Finance’s fully integrated platform with Figment’s complete staking architecture to create the optimal place for an institution to buy, store, manage, and stake ETH and other digital assets.
As a result of the integration, Crypto Finance’s clients can stake ETH, in addition to Cardano, Polkadot, and Solana. Staking ETH provides a unique opportunity for token holders to earn rewards. This solution allows institutional clients to receive the MEV-boosted rewards directly into their Crypto Finance segregated wallet, ensuring the highest level of security for staked assets throughout the entire end-to-end process. In addition, Figment’s SOC2 certified ETH architecture and “Safety over Liveness” approach minimises the risk of slashing.
By using the staking service of Crypto Finance, a FINMA-regulated institution, institutional clients can also benefit from inflation protection while claiming rewards for their active participation in a blockchain network’s proof-of-stake consensus mechanism. This strong partnership enables what is arguably the most competitive pricing approach offered by a regulated provider in the Swiss market. In addition, Crypto Finance remains the custodian of the assets throughout the whole staking lifecycle, ensuring security and control of assets.
The combination of Crypto Finance’s best-in-class security architecture and Figment’s expertise in optimising staking rewards and reliability creates a comprehensive solution that prioritises asset security, maximises returns, and ensures a trusted and dependable staking ecosystem for institutional clients.
Jan Brzezek, Founder and CEO of Crypto Finance, comments: “The partnership allows Crypto Finance to enhance its protocol staking offering by leveraging Figment’s leading staking infrastructure. Our institutional clients can now benefit from a more comprehensive, best performing, and most reliable staking partner and can potentially gain access to a broader range of staking networks beyond Ethereum. This expands their options for staking different digital assets and potentially earning staking rewards on multiple blockchains.”
Eva Lawrence, Head of EMEA at Figment, adds, “We are happy to announce our partnership with Deutsche Börse backed Crypto Finance as their only third party staking provider. Both Figment and Crypto Finance are focused on providing leading solutions in the digital asset space. Together we will enable Crypto Finance’s clients to generate secure and stable rewards for their customers and help fuel innovation and growth across Proof-of-Stake ecosystems.”
The staking integration is currently live and available to all Crypto Finance’s and Figment’s clients. To learn more, contact Figment or Crypto Finance.
Figment is the leading provider of staking infrastructure with over $3B in total assets staked. On Ethereum, we are the largest non-custodial staking provider with nearly 5% of staked ETH on Figment validators. We provide the most comprehensive staking solution for over 250 institutional clients, including asset managers, exchanges, wallets, foundations, custodians, and large token holders, to earn rewards on their digital assets. These clients rely on Figment’s institutional staking service, including rapid API development, rewards reporting, partner integrations, and slashing protection. Figment is backed by industry experts, financial institutions, and our global team across twenty-three countries. This all leads to our mission to support the adoption, growth, and long-term success of the Web3 ecosystem. To learn more about Figment, please visit our website at figment.io
Crypto Finance Group – part of Deutsche Börse Group and comprising two prudently FINMA-supervised financial institutions – offers professional digital asset solutions. This includes one of the first FINMA-approved securities firms with 24/7 brokerage services, custody, infrastructure, and tokenisation solutions for financial institutions. It also comprises the first FINMA-approved manager of collective assets for crypto assets, with a selection of crypto investment solutions, including the first FINMA-regulated crypto fund. With a team of nearly 120 employees, Crypto Finance Group is headquartered in Switzerland.
All information in this communication is provided for general information purposes. No information provided in this communication constitutes or is intended as investment advice. This communication is not, and is not intended as, an offer, recommendation, or solicitation to invest in financial instruments including crypto assets. Investments in crypto assets are high-risk investments with the risk of total loss of the investment. You should not invest in crypto assets unless you understand and can bear the risks involved. Crypto Finance is a financial group supervised by the Swiss Financial Market Supervisory Authority FINMA on a consolidated basis with Crypto Finance AG as securities company and Crypto Finance (Asset Management) AG as asset manager for collective investments with the corresponding FINMA licences. This communication and its content including any brand names, logos, designs, and trademarks and all related rights are the property of the Crypto Finance Group with Crypto Finance AG and its subsidiaries or third parties. They may not be reproduced or reused without their prior consent. This e-mail and any attachments are solely directed to the addressee. If you are not the intended recipient, please notify us.
Investments in virtual currencies are high-risk investments with the risk of total loss of the investment and you should not invest in virtual currencies unless you understand and can bear the risks involved with such investments. No information provided in this e-mail or any attachments shall constitute investment advice. Crypto Finance AG excludes its liability for any losses arising from the use of, or reliance on, information provided in this e-mail or any attachments. This e-mail and any attachments are confidential. If you are not the designated recipient, please notify the sender immediately by reply e-mail and destroy all copies (digital and paper). Any unauthorized disclosure, distribution, copying, storage or use of this message or any attachment is strictly prohibited and may be unlawful. There are risks in communicating by e-mail, such as data corruption, delay, interception, and unauthorized amendment for which we do not accept liability. Anyone who communicates with us by e-mail assumes such risks.
Media Inquiries Figment: [email protected]; Media Inquiries Crypto Finance Group: Jutta Holtkötter, [email protected], +41 41 552 45 82
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
“Grand Huangshan” Debuts at the 2024 World Brand Moganshan Conference
-
Latest News6 days ago
AI-powered Panax raises $15m to reshape cash flow management
-
Latest News7 days ago
Yili’s 2023 Revenue Reaches 126.2 Billion Yuan, Leading Global Dairy Industry towards Healthy and Sustainable Development
-
Latest News6 days ago
Egypt’s Swypex launches an all-in-one fintech platform after $4m seed round
-
Latest News6 days ago
Sweden’s Mitigram names Pedram Tadayon as new CEO
-
Latest News6 days ago
Sobha Developers bring to Singapore an Exclusive Dubai Property Showcase
-
Latest News6 days ago
South African fintech Lesaka snaps up Adumo in $86m deal
-
Latest News5 days ago
Al Hassan Ghazi Ibrahim Shaker Co. announces a strong start to FY24, reporting a 12.09% YoY increase in net profit to reach SAR 32.25 million in Q1-FY24